Please assess the completion status of the following clinical trial:

Trial Title: The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontinuation of Clopidogrel

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female subject ≥ 18 years of age eligible for PCI with at least one drug eluting stent (name: Xience) implanted in all clinical situations excluding primary PCI for acute MI and treatment of the left main artery.~* Male or female subject ≥ 18 years of age eligible for PCI with at least one DES Xience.~* Patient not pre-treated with protein IIb/IIIa inhibitors (name: abxicimab or eptifibatide) during hospitalization~* Patient pre-treated with aspirin and clopidogrel before PCI~* ASA check at least 24 hours after the interruption of tirofiban~* The subject has given written informed and dated consent to participate in this study.~Exclusion Criteria:~* Subjects not able to give informed consent~* Prior implantation of DES~* Known platelets \< 100 000/µl or known hemorrhagic diathesis~* Oral anticoagulation or treatment with abxicimab or eptifibatide during hospitalization~* ASA check less than 24 hours after the interruption of tirofiban~* Thrombolytic therapy within 4 days before ASA check~* Contra-indication to aspirin or clopidogrel~* Recent major surgery \< 6 weeks~* Evidence of an active gastrointestinal or urogenital bleeding~* Severe liver insufficiency~* Primary PCI for acute MI~* Left main PCI~* Any scheduled surgery during the year after enrollment~* Severe concomitant disease with life expectation \< two years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).